Literature DB >> 308099

Evidence that serotonin mediates some behavioral effects of amphetamine.

R S Sloviter, E G Drust, J D Connor.   

Abstract

In the rat, d-amphetamine sulfate (15--80 mg/kg) causes numerous behavioral effects including simultaneous side-to-side head weaving or head tremor, forepaw padding and splayed hindlimbs. These signs are strikingly similar to a behavioral syndrome caused by intense serotonin (5-HT) receptor activation. Experiments were designed to determine whether some of the numerous effects of amphetamine on behavior can be ascribed to actions of the drug on 5-HT mechanisms. Catecholamine depletion with alpha-methyl-p-tyrosine did not prevent the amphetamine syndrome. However, 5-HT depletion with 5,7-dihydroxytryptamine or with p-chlorophenylalanine did prevent the syndrome. The degree of syndrome inhibition by p-chlorophenylalanine was correlated with the extent of 5-HT depletion. Normal responsiveness to amphetamine in p-chlorophenylalanine-treated rats was restored by 5-hydroxytryptophan, the precursor of 5-HT. Furthermore, methysergide, a 5-HT receptor blocker, prevented the amphetamine syndrome, whereas catecholamine blockers, phenoxybenzamine and pimozide, were ineffective. The results suggest that when amphetamine causes the signs of the syndrome it does so by activating 5-HT receptors in the brain, probably by displacement of endogenous 5-HT.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308099

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Interaction between antidepressants and d-amphetamine on variable-interval performance.

Authors:  K Shah; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Effects of amphetamine, methylphenidate, and apomorphine on regional brain serotonin and 5-hydroxyindole acetic acid.

Authors:  R Kuczenski; D S Segal; N J Leith; C D Applegate
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  5HT-2 mediation of acute behavioral effects of hallucinogens in rats.

Authors:  L L Wing; G S Tapson; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Separate mechanisms for behavioral, cardiovascular, and hormonal responses to dextroamphetamine in man.

Authors:  J I Nurnberger; S Simmons-Alling; L Kessler; S Jimerson; J Schreiber; E Hollander; C A Tamminga; N S Nadi; D S Goldstein; E S Gershon
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Reduction of 3H-spiroperidol binding in rat striatum and frontal cortex by chronic amphetamine: dose response, time course and role of sustained dopamine release.

Authors:  E B Nielsen; M Nielsen; C Braestrup
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

6.  The effects of amfonelic acid on 5-HT metabolism in rat brain.

Authors:  P C Waldmeier; A M Buchle; K Stoecklin; B Fehr; J J Feldtrauer
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

Review 7.  Drugs for stroke recovery: the example of amphetamines.

Authors:  Louise Martinsson; Staffan Eksborg
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

8.  Blockade of dopamine receptors explains the lack of 5-HT stereotypy on treatment with the putative 5-HT1A agonist LY165163.

Authors:  T P Donohoe; P H Hutson; G Curzon
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

9.  Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: in vivo microdialysis study.

Authors:  M Matsumoto; M Yoshioka; H Togashi; T Ikeda; H Saito
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-05       Impact factor: 3.000

10.  5-Hydroxytryptamine involvement in the locomotor activity suppressant effects of amphetamine in the mouse.

Authors:  A J Bradbury; B Costall; R J Naylor; E S Onaivi
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.